Investor Relations
Heska Corporation (NASDAQ: HSKA) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. Heska Corporation is traded on the NASDAQ under the ticker symbol HSKA.

Heska manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. Heska’s business is composed of Core Companion Animal Health (“CCA”) and Other Vaccines, Pharmaceuticals and Products (“OVP”). CCA includes, primarily for canine and feline use, point of care laboratory testing instruments and supplies under a unique multi-year Reset Subscription model, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings such as in-clinic diagnostic tests and heartworm preventive products. OVP includes, primarily for herd animal health, private label vaccine and pharmaceutical production under third party agreements and channels. Heska’s core focus is to provide state-of-the-art, high-value products and unparalleled customer support.

JP Morgan Conference Q&A | January 10, 2018
JP Morgan Conference Presentation | January 10, 2018 | 11:00AM PT
Heska to Present at Jefferies 2018 London Healthcare Conference Webcast | November 14th | 2:00PM UTC/GMT in London, UK
Third Quarter 2018 Earnings Call
Second Quarter 2018 Earnings Call Webcast | August 7th | 11:00AM ET
Analyst Day | May 15, 2018 | 8:45AM ET
Heska Corporation First Quarter 2018 Earnings Call | May 4, 2018 | 11:00AM ET
Annual Meeting of Stockholders Webcast | May 3, 2018 | 11:00AM ET
Fourth Quarter and Year End 2017 Earnings Call | February 28, 2018 | 11:00AM ET
Third Quarter 2017 Earnings Call